Group 1 - The company is currently in the process of applying for biological testing for its human-derived type III collagen medical devices [2] - The inquiry about the progress of the company's restructuring of human-derived type III collagen medical devices was made by an investor on an interactive platform [2] - The company provided an update on February 11 regarding the status of its medical device applications [2]